CAV1 and prostate cancer: These claims were further substantiated by studies in Cav1-positive PC3 prostate cancer cells lacking cavin-1 and hence devoid of caveolae [4] in which Cav1 siRNA knockdown, specifically eliminating scaffolds, reduces downstream Rho signaling, focal adhesion signaling and cell migration.